OSCR vs. MRK
OSCR (Oscar Health, Inc.) and MRK (Merck & Co., Inc.) are both stocks. Both are in the Healthcare sector — OSCR in Healthcare Plans, MRK in Drug Manufacturers - General. Over the past 5 years, OSCR returned -1.69%/yr vs 13.69%/yr for MRK. At a 0.05 correlation, their price movements are largely independent.
Performance
OSCR vs. MRK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OSCR achieves a 64.23% return, which is significantly higher than MRK's 15.10% return.
OSCR
- 1D
- 15.12%
- 1M
- 31.55%
- YTD
- 64.23%
- 6M
- 37.37%
- 1Y
- 66.78%
- 3Y*
- 41.67%
- 5Y*
- -1.69%
- 10Y*
- —
MRK
- 1D
- 4.85%
- 1M
- 6.28%
- YTD
- 15.10%
- 6M
- 21.11%
- 1Y
- 59.23%
- 3Y*
- 5.24%
- 5Y*
- 13.69%
- 10Y*
- 11.61%
OSCR vs. MRK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
OSCR Oscar Health, Inc. | 64.23% | 6.92% | 46.89% | 271.95% | -68.66% | -77.44% |
MRK Merck & Co., Inc. | 15.10% | 9.79% | -6.26% | 1.01% | 49.42% | 13.55% |
Correlation
The correlation between OSCR and MRK is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.05 |
Correlation (All Time) Calculated using the full available price history since Mar 4, 2021 | 0.05 |
Fundamentals
OSCR:
$7.78B
MRK:
$297.28B
OSCR:
-$0.14
MRK:
$3.58
OSCR:
0.51
MRK:
4.57
OSCR:
4.68
MRK:
6.48
OSCR:
$13.30B
MRK:
$65.59B
OSCR:
$895.79M
MRK:
$49.79B
OSCR:
$19.23M
MRK:
$22.69B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OSCR vs. MRK — Risk / Return Rank
OSCR
MRK
OSCR vs. MRK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Oscar Health, Inc. (OSCR) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| OSCR | MRK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.32 | ||
| Sortino ratioReturn per unit of downside risk | -1.49 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.38 | -0.17 |
| Calmar ratioReturn relative to maximum drawdown | 1.30 | 5.24 | -3.94 |
| Martin ratioReturn relative to average drawdown | 2.41 | 13.14 | -10.73 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| OSCR | MRK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.86 | 2.18 | -1.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.02 | 0.58 | -0.60 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.09 | 0.48 | -0.57 |
Drawdowns
OSCR vs. MRK - Drawdown Comparison
The maximum OSCR drawdown since its inception was -94.15%, which is greater than MRK's maximum drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for OSCR and MRK.
Loading charts...
Drawdown Indicators
| OSCR | MRK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.15% | -68.61% | -25.54% |
Max Drawdown (1Y)Largest decline over 1 year | -51.71% | -11.37% | -40.34% |
Max Drawdown (3Y)Largest decline over 3 years | -53.39% | -43.44% | -9.95% |
Max Drawdown (5Y)Largest decline over 5 years | -92.65% | -43.44% | -49.21% |
Max Drawdown (10Y)Largest decline over 10 years | — | -43.44% | — |
Current DrawdownCurrent decline from peak | -35.82% | -4.06% | -31.76% |
Average DrawdownAverage peak-to-trough decline | -65.18% | -18.84% | -46.34% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 27.81% | 4.52% | +23.29% |
Volatility
OSCR vs. MRK - Volatility Comparison
Oscar Health, Inc. (OSCR) has a higher volatility of 25.17% compared to Merck & Co., Inc. (MRK) at 9.44%. This indicates that OSCR's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OSCR | MRK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.17% | 9.44% | +15.73% |
Volatility (6M)Calculated over the trailing 6-month period | 44.26% | 18.19% | +26.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 78.12% | 27.31% | +50.81% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 80.75% | 23.72% | +57.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.95% | 22.96% | +56.99% |
Dividends
OSCR vs. MRK - Dividend Comparison
OSCR has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 2.76%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 2.76% | 3.12% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% |
OSCR Oscar Health, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
OSCR vs. MRK - Financials Comparison
This section allows you to compare key financial metrics between Oscar Health, Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
OSCR vs. MRK - Profitability Comparison
OSCR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported a gross profit of 0.00 and revenue of 4.65B. Therefore, the gross margin over that period was 0.0%.
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.
OSCR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported an operating income of 704.09M and revenue of 4.65B, resulting in an operating margin of 15.2%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.
OSCR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Oscar Health, Inc. reported a net income of 679.00M and revenue of 4.65B, resulting in a net margin of 14.6%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.
Frequently Asked Questions
OSCR and MRK have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OSCR has higher volatility (25.17%) compared to MRK (9.44%). In terms of maximum drawdown, OSCR dropped -94.15% vs MRK's -68.61%.
MRK currently has the higher Sharpe Ratio (2.18 vs 0.86), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OSCR and MRK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer